about
Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosisA functional chimaeric S-layer-enhanced green fluorescent protein to follow the uptake of S-layer-coated liposomes into eukaryotic cells.Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis.Optimizing efficacy of amphotericin B through nanomodification.Rapid preparation of giant unilamellar vesiclesMicroencapsulation technology by nature: Cell derived extracellular vesicles with therapeutic potentialPharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem celIn vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit.Liposomal bupivacaine: a review of a new bupivacaine formulationDrug Delivery Systems for Imaging and Therapy of Parkinson's Disease.Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo.Acyl chain orientational order in large unilamellar vesicles: comparison with multilamellar liposomes: a 2H and 31P nuclear magnetic resonance study.A modified spectroscopic method for the determination of the transbilayer distribution of phosphatidylethanolamine in soya-bean asolectin small unilamellar vesicles.Systematic review and meta-analysis of the efficacy of liposomal bupivacaine in colorectal resections.
P2860
Q24564481-AA009345-73FD-47D1-A53D-A4BC0473AB7BQ33196837-70CB8499-6638-42FB-BF20-09505999FF3DQ33978764-740E9FA5-F6C4-4A5F-AEFD-DFDEDCE377B6Q35516397-0DB3F368-0942-40B3-A2E7-3116D668BEBEQ35899686-513C104C-AAE7-4A44-9010-AE1B06BD834EQ36920328-DE05AB9D-9560-45ED-9DA9-42D00F7327CFQ37253450-A8CCD998-A694-4D88-BB36-3FC85FCE63E1Q37320015-4B1B606D-C057-4EA1-97AB-6DA9B4F53A7BQ37333175-3F96B9B0-8D9F-437F-8FEA-36571CF8DE3AQ37639117-4B15BFBA-3222-4985-B65D-AC248872E213Q38050749-23ECE609-BAC6-42A2-BFF4-13650B185680Q38682342-40B04AEF-B0CC-4F7D-8D11-C40AF430529DQ41833192-08CFE686-4752-4F66-BD3E-C6E39F4DB1EEQ41864601-522B887F-69FB-48AE-AB16-A75289413C4CQ42822805-A66FCAD5-2BC7-4572-9F75-86933A15513AQ55519305-F31063DE-31EB-4533-932C-1BE160F3F52A
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Use of liposomes as injectable-drug delivery systems.
@en
type
label
Use of liposomes as injectable-drug delivery systems.
@en
prefLabel
Use of liposomes as injectable-drug delivery systems.
@en
P1476
Use of liposomes as injectable-drug delivery systems.
@en
P2093
P304
P577
1989-08-01T00:00:00Z